| Overview |
| bs-0056R-Cy5 |
| Insulin Polyclonal Antibody, Cy5 Conjugated |
| IF(IHC-P) |
| Human, Mouse, Rat |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Insulin |
| 45-95/110 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at 4°C for 12 months. |
| Target |
| 3630 |
| P01308 |
| Secreted |
| ILPR; IRDN; IDDM1; IDDM2; MODY1; Insulin; INS |
| Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. |
| Application Dilution |
| IF(IHC-P) |
1:50-200 |